Timothy Miller, MD, PhD
David Clayson Professor of Neurology
New, effective, and safe treatments for neurodegenerative diseases Read More
|Lab Phone:||(314) 362-8169|
|Lab Location:||Biotech 115/117|
|Keywords:||ALS, FTD, miRNA, SOD1, tau, TDP-43, mitochondria, eurodegeneration, antisense oligonucleotides|
New, effective, and safe treatments for neurodegenerative diseases
The Miller Laboratory is dedicated to understanding neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and dementias, in order to develop new, effective, and safe treatments. Part of the Department of Neurology at Washington University School of Medicine in St. Louis, the Miller Laboratory is headed by Timothy M. Miller, MD, PhD, the David Clayson Professor of Neurology. Dr. Miller is a national leader in translational neuroscience and new therapeutic approaches for neurodegenerative diseases.
Updated January 2016
Hope Center Affiliations
Real-time Scopus search.